EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1351)	11/5/1998 7:41:00 AM
From: Mark Bartlett	Read Replies (1) of 2135

Peter, OFF TOPIC Been following this thread as a lurker with interest for some time. There is a small company in Ontario, Canada that is starting phase III trials (in the US) of a drug called WF10. The drug is an immunomodulator. It acts by bring the immune system back into a state of homeostasis. Phase II trials on late-stage AIDS patients were excellent. The drug has shown a lot of promise in some cancers - certain trials are ongoing there too. It is not my intention to pollute this thread - just thought some might be interested due to the nature of the discussion here. If anyone is interested, they have a web site at: dimethaid.com Also a thread on S/I too. The company has another drug for arthritis pain relief that we are hoping will get approval by the FDA, the UK and HPD within the first Q99. If approved, it will be the first topical NSAID in N/A approved as such. This is my last post here ... if anybody would like to discuss with me - you know where to find me. Best of luck here. MB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next